By Editor , 17 September 2026
Olin-Huntsman Merger Clears US Antitrust Review, Nears Closing

Clayton, Mo. and The Woodlands, Texas – – September 16, 2026 -- Olin Corporation (NYSE: OLN) and Huntsman Corporation (NYSE: HUN) confirmed that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act has expired, clearing a key regulatory hurdle for their planned merger of equals.

HSR clearance removes a major closing condition for the chemical sector merger

The expiration satisfies one of the primary conditions required to close the transaction, though the deal still awaits additional regulatory approvals that are currently underway.

By Editor , 17 September 2026

Los Angeles – September 16, 2026 -- DJS Law Group has reminded shareholders of a class action lawsuit filed against EquipmentShare.com Inc. (NASDAQ: EQPT), alleging the company violated federal securities law by concealing related-party transactions from investors.

By Editor , 17 September 2026
Missouri Law HB 2974 Speeds Licensing, Expands Telehealth Access

Kansas City, Mo. – September 16, 2026 -- Missouri Governor Mike Kehoe joined nonpartisan think tank United WE at its Kansas City headquarters on September 10 for a ceremonial signing of House Bill 2974, a law that shortens licensing wait times for out-of-state professionals and clarifies telehealth rules for providers with reciprocal Missouri licenses. The bill was formally signed on July 13 and took effect August 28.

By Editor , 17 September 2026

Houston – September 16, 2026 -- Nutex Health Inc. (NASDAQ: NUTX) disclosed that the unauthorized third party behind its previously reported cybersecurity breach has now published on its own website the data allegedly stolen from the healthcare operator's network.

By Editor , 17 September 2026
Experts Issue First Global Consensus on Type 1 Diabetes Screening

New York – September 16, 2026 -- A consensus paper published in Diabetologia establishes the first international framework for population-wide screening of type 1 diabetes (T1D), setting concrete age thresholds and testing protocols for clinical adoption.

By Editor , 17 September 2026
We Card Marks 31st Awareness Month as FDA Scrutiny Persists

Arlington, Va. – – September 16, 2026 -- The We Card Program is marking its 31st annual Awareness Month this September by pushing retailers nationwide to tighten age-verification training as FDA enforcement of tobacco, vapor and nicotine pouch sales remains a priority.

By Editor , 17 September 2026
Cardiol Therapeutics Files US$150M Shelf Prospectus, Expands OSC Disclosure

Toronto – September 16, 2026 -- Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) has filed a preliminary short form base shelf prospectus in Canada and a corresponding Form F-10 registration statement with the U.S. SEC, enabling the life sciences company to raise up to US$150 million over a 25-month period.

By Editor , 17 September 2026
Lode Gold Expands Fremont Drill Program With Four New Pads

Vancouver – September 16, 2026 -- Lode Gold Resources Inc. (TSXV: LOD) (OTCQB: LODFF) has expanded its drill program at the 100%-owned Fremont Gold Mine in Mariposa County, California, adding four new drill pads through an amendment to its existing Authorized Use Permit rather than seeking a new regulatory approval.

By Editor , 17 September 2026
Hikma's Epinephrine Nasal Spray Advances Through FDA, EU, UK Review

London – September 16, 2026 -- Hikma Pharmaceuticals PLC said regulators in the United States, Europe, and the UK have accepted for review its investigational epinephrine nasal spray, a needle-free treatment for anaphylaxis, with an additional filing lodged in Canada.